TIOTROPIUM/OLODATEROL (Spiolto Respimat®)

Clinical Indication

COPD

Comments

NEW LABA/LAMA combination product – to be used in line with updated COPD Guidelines

Date of classification

December 2015

Green

Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.